Ki Tae Suk Selected Research

Anti-Bacterial Agents (Antibiotics)

2/2022	A Multicenter Retrospective Study on Clinical Characteristics and Outcome of Pyogenic Liver Abscess Focusing Multidrug-Resistant Organisms.
12/2020	The Role of the Gut Microbiome in Liver Cirrhosis Treatment.
12/2018	Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ki Tae Suk Research Topics

Disease

18	Fibrosis (Cirrhosis) 04/2021 - 01/2008
13	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 12/2007
12	Infections 02/2022 - 08/2008
11	Non-alcoholic Fatty Liver Disease 12/2021 - 05/2013
8	Liver Diseases (Liver Disease) 01/2022 - 01/2013
8	Chronic Hepatitis B 01/2022 - 04/2011
7	Inflammation (Inflammations) 05/2021 - 05/2011
6	Hepatocellular Carcinoma (Hepatoma) 11/2020 - 11/2009
5	End Stage Liver Disease 10/2021 - 11/2009
5	Alcoholic Hepatitis 01/2021 - 09/2014
5	Hemorrhage 11/2018 - 12/2007
4	Neoplasms (Cancer) 04/2022 - 10/2006
4	Dysbiosis 10/2021 - 01/2019
4	Ascites 04/2021 - 01/2016
4	Hepatitis 01/2018 - 09/2012
4	Cholecystitis 06/2014 - 10/2006
3	Obesity 05/2021 - 01/2012
3	Fatigue 05/2021 - 07/2016
3	Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis) 11/2020 - 12/2016
3	Insulin Resistance 06/2019 - 01/2012
3	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2015 - 07/2012
3	Stomach Neoplasms (Stomach Cancer) 12/2012 - 06/2009
3	Gastritis 12/2011 - 08/2003
2	Polyps 04/2022 - 06/2014
2	Hypertension (High Blood Pressure) 05/2021 - 06/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2021 - 02/2013
2	Fatty Liver 03/2021 - 05/2013
2	Chronic Hepatitis C 01/2020 - 12/2011
2	Dyspepsia (Indigestion) 01/2015 - 12/2012
2	Portal Hypertension 03/2014 - 12/2007
2	Cholangitis 10/2007 - 10/2006
2	Peptic Esophagitis (Reflux Esophagitis) 03/2004 - 08/2003
1	Sclerosing Cholangitis 05/2022
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 05/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Abdominal Obesity 05/2021
1	Hyperglycemia 05/2021
1	Disease Progression 02/2021

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 12/2021 - 04/2011
4	EnzymesIBA 03/2021 - 10/2017
4	CreatinineIBA 12/2020 - 11/2016
4	LipopolysaccharidesIBA 05/2019 - 01/2015
4	Hyaluronic Acid (Hyaluronan)IBA 09/2012 - 06/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2022 - 12/2018
3	CytokinesIBA 12/2021 - 05/2011
3	LipidsIBA 11/2021 - 01/2013
3	Cytidine Triphosphate (CTP)IBA 10/2021 - 04/2021
3	AntioxidantsIBA 05/2021 - 05/2013
3	Clarithromycin (Biaxin)FDA LinkGeneric 02/2021 - 05/2015
3	CholesterolIBA 01/2021 - 06/2014
3	BilirubinIBA 05/2020 - 03/2009
3	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2012
3	urushiolIBA 07/2014 - 12/2011
3	Matrix Metalloproteinase 2 (Gelatinase A)IBA 09/2012 - 04/2011
2	Bile Acids and Salts (Bile Acids)IBA 12/2021 - 10/2021
2	EndotoxinsIBA 10/2021 - 05/2019
2	Triglycerides (Triacylglycerol)IBA 05/2021 - 05/2013
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2021 - 01/2013
2	Transaminases (Aminotransferases)IBA 03/2021 - 01/2013
2	Omeprazole (Prilosec)FDA LinkGeneric 02/2021 - 03/2004
2	Metronidazole (Metric)FDA LinkGeneric 02/2021 - 01/2020
2	Biological ProductsIBA 01/2021 - 03/2015
2	Cystatin CIBA 12/2020 - 04/2018
2	Serum AlbuminIBA 05/2020 - 01/2016
2	Branched-Chain Amino AcidsIBA 05/2020 - 06/2017
2	InterferonsIBA 01/2020 - 04/2016
2	BismuthIBA 01/2020 - 11/2018
2	Amoxicillin (Wymox)FDA LinkGeneric 01/2020 - 05/2015
2	Toll-Like Receptor 4IBA 01/2019 - 01/2015
2	entecavir FDA Link 03/2017 - 01/2016
2	SodiumIBA 01/2017 - 11/2009
2	CollagenIBA 12/2016 - 06/2008
2	Proton Pump InhibitorsIBA 05/2015 - 03/2004
2	Therapeutic UsesIBA 01/2015 - 03/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2014 - 09/2014
2	Pentoxifylline (Trental)FDA LinkGeneric 10/2014 - 09/2014
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 05/2013 - 07/2012
2	AntigensIBA 02/2013 - 01/2013
2	ProcollagenIBA 09/2012 - 06/2008
2	HaptoglobinsIBA 09/2012 - 12/2011
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 09/2012 - 12/2011
2	Peptides (Polypeptides)IBA 09/2012 - 12/2011
2	Hydroxyproline (4 Hydroxyproline)IBA 07/2012 - 06/2008
1	Capsules (Microcapsules)IBA 04/2022
1	indoleIBA 12/2021
1	Tryptophan (L-Tryptophan)FDA Link 12/2021
1	HDL LipoproteinsIBA 05/2021
1	Alanine (L-Alanine)FDA Link 03/2021
1	Volatile Fatty AcidsIBA 02/2021
1	Rifaximin (L 105)FDA Link 01/2021
1	PrebioticsIBA 12/2020
1	Acetylglucosaminidase (NAGase)IBA 12/2020

Therapy/Procedure

24	Therapeutics 05/2022 - 03/2004
2	Transplantation 06/2019 - 12/2016
2	Ligation 01/2018 - 06/2008
2	Stents 10/2007 - 10/2006
1	Fecal Microbiota Transplantation 01/2022
1	Vagus Nerve Stimulation 02/2021
1	Oral Administration 02/2021